219 related articles for article (PubMed ID: 26769703)
1. The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.
Franczyk B; Gluba-Brzózka A; Ciałkowska-Rysz A; Banach M; Rysz J
Curr Vasc Pharmacol; 2016; 14(3):260-5. PubMed ID: 26769703
[TBL] [Abstract][Full Text] [Related]
2. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
3. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.
Tomaszuk-Kazberuk A; Nikas D; Lopatowska P; Młodawska E; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Sobkowicz B; Goudevenos I
Kidney Blood Press Res; 2018; 43(6):1796-1805. PubMed ID: 30504712
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
5. Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.
Ghadban R; Flaker G; Katta N; Alpert MA
Hemodial Int; 2017 Oct; 21 Suppl 2():S47-S56. PubMed ID: 29064182
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
7. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines.
Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J
Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343
[TBL] [Abstract][Full Text] [Related]
9. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.
Potpara TS; Ferro CJ; Lip GYH
Nat Rev Nephrol; 2018 May; 14(5):337-351. PubMed ID: 29578207
[TBL] [Abstract][Full Text] [Related]
10. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
[TBL] [Abstract][Full Text] [Related]
11. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
12. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation therapy and stroke prevention in hemodialysis patients.
Melenovský V; Osmančík P
Kardiol Pol; 2023; 81(12):1193-1204. PubMed ID: 38189503
[TBL] [Abstract][Full Text] [Related]
14. [Atrial fibrillation and stroke].
Mattle HP; Schwerzmann M; Seiler Ch
Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
[TBL] [Abstract][Full Text] [Related]
15. Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials.
Proietti M; Lane DA; Lip GYH
EBioMedicine; 2016 Jun; 8():309-316. PubMed ID: 27428440
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
17. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
18. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
Albert NM
Heart Lung; 2014; 43(1):48-59. PubMed ID: 24373340
[TBL] [Abstract][Full Text] [Related]
19. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
[TBL] [Abstract][Full Text] [Related]
20. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]